The National Association of Medicaid Directors released a public memo which discusses average acquisition cost (AAC) methodologies for Medicaid prescription drug reimbursement. The memo also provides an update on CMS’s progress finalizing average market price-based Federal Upper Limits (AMP-based FULs) for prescription drugs.
- In the NAMD newsletter: Brian Neale leaves CMS; Work Requirement Lawsuit; Indiana Waiver Extended; Happenings on the Hill; January MACPAC. February 7, 2018
- In the newsletter: New guidance on community engagement; Kentucky work requirement waiver approved; MedPAC & MACPAC, Beneficiaries Dually Eligible for Medicare and Medicaid. January 23, 2018
- Happy New Year! In the newsletter we cover Healthcare choice and competition; substance abuse; Mississippi Section 1115 demonstration; opioids; Hill happenings. January 9, 2018